Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-9-17
|
pubmed:abstractText |
The prevalence of hepatitis B virus (HBV) markers was assessed in 1,841/2,178 (84.5%) dialysis patients (DP) cared for in 38/47 dialysis units (80.9%) in Latium. Among DP, 205 (11.1%) were HBsAg positive: 13.8% of males and 7.1% of females (p less than 0.001); the prevalence increased with the length of time on dialysis (p for trend less than 0.001). No differences in HBV (HBsAg and/or anti-HBc) distribution were seen related to age and sex. Of 664/1,539 vaccinated DP, 150 (22.6%) were anti-HBc positive and 239 (36.0%) positive for anti-HBs alone. Of 875/1,539 nonvaccinated patients, 146 (16.7%) had no HBV marker. Vaccination against HBV did not influence the diffusion of HBV in our dialysis units and must be coupled with the implementation of long-standing infection control strategies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-2766
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-30
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1386906-Female,
pubmed-meshheading:1386906-Hemodialysis Units, Hospital,
pubmed-meshheading:1386906-Hepatitis B,
pubmed-meshheading:1386906-Hepatitis B Vaccines,
pubmed-meshheading:1386906-Humans,
pubmed-meshheading:1386906-Infection Control,
pubmed-meshheading:1386906-Italy,
pubmed-meshheading:1386906-Male,
pubmed-meshheading:1386906-Renal Dialysis,
pubmed-meshheading:1386906-Viral Hepatitis Vaccines
|
pubmed:year |
1992
|
pubmed:articleTitle |
Control of hepatitis B virus infection in dialysis units in Latium, Italy.
|
pubmed:affiliation |
Department of Public Health, 2nd University, Rome, Italy.
|
pubmed:publicationType |
Journal Article
|